Atherosclerotic renovascular disease (ARVD) is a disease of ageing. It is usually a manifestation of widespread vascular disease and although it may be symptomless, many patients with ARVD present with the effects of extra-renal vascular disease, such as peripheral vascular (PVD), coronary heart (CHD) and cerebrovascular disease. ARVD is a common cause of hypertension and chronic renal failure (CRF), and it is one of the most common renal diagnoses in elderly patients accepted on to dialysis programmes with end-stage renal failure (ESRF). The cause of renal impairment in these patients is still a matter of debate. Patients with ARVD have a high mortality, especially those with renal failure. In this review we examine the relationships between ARVD and co-morbid extra-renal vascular disease, and the impact of these associated vascular pathologies upon renal functional and mortality outcomes is considered. The latest evidence concerning the likely pathogenesis of renal dysfunction in patients with ARVD is also reviewed.

1.
Rudnick KV, Sackell DL, Hirst S, Holmes C: Hypertension in family practice. Can Med Assoc 1997;117:492–497.
2.
Preston RA, Epstein M: Ischaemic renal disease: An emerging cause of chronic renal failure and end stage renal disease. Am J Hypertens 1997;15:1365–1377.
3.
Mailloux LU, Napolitano B, Belluci AG, Vernace M, Wilkes BM, Mossy RT: Renal vascular disease causing end stage renal disease, incidence, clinical correlates and outcome: A 20 year experience. Am J Kid Dis 1994;24:622–629.
4.
O’Neil EA, Hansen KJ, Canzanello VJ, Pennell TC, Dean RH: Prevalence of ischaemic nephropathy in patients with renal insufficiency. Am J Surg 1992;58:485–490.
5.
Herrara AH, Davidson RA: Renovascular disease in older adults. Clin Geriatr Med 1998;14:237–253.
6.
Connolly JO, Higgins RM, Walters H: Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. Quart J Med 1994;87:413–421.
7.
Messina LM, Zelenock GB, Yaok A, Stanley JC: Renal revascularization for recurrent pulmonary oedema in patients with poorly controlled hypertension and renal insufficiency: A distinct subgroup of patients with atherosclerotic renal artery occlusive disease. J Vasc Surg 1992;15:73–78.
8.
Kalra PA, Mamtora H, Holmes AM, Waldek S: Renovascular disease and renal complications of angiotensin converting enzyme inhibitor therapy. Q J Med 1990;282:1013.
9.
Choudhri AH, Cleland JGF, Rowlands PC, Tran TL, McCarthy M, Al Kutoubi MA: Unsuspected renal artery stenosis in peripheral vascular disease. Br Med J 1990;301:1197–1198.
10.
Harding MB, Smith LR, Himmelstein SI, Harrison K, Philips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashmore TM: Renal artery stenosis: Prevalence and associated risk in patients undergoing routine cardiac catheterisation. J Am Soc Nephrol 1992;2:1608–1616.
11.
Wollenweber J, Sheps SG, Davis GD: Clinical course of atherosclerotic renovascular disease. Am J Med 1968;21:60–70.
12.
Scoble JE, Maher ER, Humilton G, Dick R, Sweny P, Moorehead JF: Atherosclerotic renovascular disease causing renal impairment: A case for treatment. Clin Nephrol 1989;31:119–122.
13.
Jean WJ, AL Bitar I, Zwicke DL, Port SC, Schmidt DH, Dajura TK: High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiol Diagn 1994;32:8–10.
14.
Vetrovec GW, Landwehr DM, Edwards VL: Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography. J Intervent Cardiol 1989;2:9–76.
15.
Crowley JJ, Santos RM, Peter RH, Puma JA, Schwab SJ, Philips HR, Stack RS, Conlon PJ: Progression of renal artery stenosis in patients undergoing cardiac catheterisation. Am Heart J 1998;136:913–918.
16.
Uzu T, Inoue T, Fujii T, Nakamura S, Inenaga T, Yutani C, Kimura G: Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 1997;29:733–738.
17.
Meissner MD, Wilson AR, Jessup M: Renal artery stenosis in heart failure. Am J Cardiol 1988;62:1307–1308.
18.
MacDowall P, Kalra PA, O’Donoghue DJ, Mamtora H, Waldek S, Brown K: Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998;352:13–16.
19.
Textor SC: Renal failure related to angiotensin converting enzyme inhibitor. Semin Nephrol 1997;17:67–76.
20.
Ducloux D, Jamali M, Chalopin JM: Chronic congestive cardiac failure associated with bilateral renal artery stenosis. Clin Nephrol 1997;48:54–55.
21.
Conlon PJ, Athirakul K, Kovalik E, Schwab SJ, Crowley J, Stack R, McCants CB Jr, Mark DB, Bashore TM, Alberts F: Survival in renal vascular disease. J Am Soc Nephrol 1998;9:252–256.
22.
Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA: Renal artery stenosis: A common and important problem in patients with peripheral vascular disease. Am J Med 1994;96:10–14.
23.
Wilms G, Marchal G, Peene P, Baert AL: The angiographic incidence of renal artery stenosis in the atherosclerotic population. Eur J Radiol 1990;10(3):195–197.
24.
Olin JW, Melia M, Young JR, Graor RA, Risius B: Prevalence of Atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990;88:46N–51N.
25.
Valentine RJ, Myers SI, Miller GL, Lopez MA, Clagett GP: Detection of unsuspected renal artery stenosis in patients with abdominal aortic aneurysm: Refined indication for pre-operative aortography. Ann Vasc Surg 1993;7:220–224.
26.
Brewster DC, Retana A, Waltman AC, Darling RC: Angiography in the management of the abdominal aorta: Its value and safety. N Engl J Med 1975;292:822–825.
27.
Kuroda S, Nishida N, Uzu T, Takeji M, Nishimura M, Fuji T, Nakamura S, Inenaga T, Yutani C, Kimura G: Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 2000;31:61–65.
28.
Louie J, Isaacson JA, Zierler RE, Bergelin RO, Strandness DE Jr: Prevalence of carotid and lower extremity arterial disease in patients with renal artery stenosis. Am J Hypertens 1994;7:436–439.
29.
Zierler RE, Bergelin RO, Polissar NL, Beach KW, Caps MT, Cantwell-Gab K, Davidson RC, Strandness DE Jr: Carotid and lower extremity arterial disease in patients with renal artery atherosclerosis. Arch Intern Med 1998;13:761–767.
30.
Missouris CG, Papavassiliou MB, Khaw K, Hall T, Belli AM, Buckenham T, MacGregor GA: High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant 1998;13:945–948.
31.
Shurrab A, Mamtora H, O’Donoghue DJ, Waldek S, Kalra PA: Increasing the diagnostic yield of renal angiography for the diagnosis of atheromatous renovascular disease. Br J Radiol 2001;74:1–6.
32.
Schreiber MF, Pohl MA, Novick AC: The natural history of Atherosclerotic and fibrous renal artery disease. Urol Clin N Am 1984;11:383–392.
33.
Zierler RE, Bergelin RO, Isaacson JA, Strandness DE Jr: Natural history of Atherosclerotic renal artery stenosis: A prospective study with duplex ultrasonography. J Vas Surg 1994;19:250–258.
34.
Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness DE Jr: A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 1996;9:1055–1061.
35.
Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach kW, Cantwell-Gab K, Casadei A, Davidson RC, Strandness DE Jr: Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998;53:735–742.
36.
Jensen G, Zachrisson B-F, Delin K, Volkmann R, Aurell M: Treatment of renovascular hypertension: One-year result of renal angioplasty. Kidney Int 1995;48:1936–1945.
37.
Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM, Sheedy PF, Welch TJ, Schirger A: Renal artery angioplasty: Technical results and outcome in 320 patients. Mayo Clinic Proc 1995;70:1041–1052.
38.
Van de Ven PJG, Kaatee R, Beutler JJ, Beek FJA, Woittiez AJ, Buskens E, Koomans HA, Mali WPT: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet 1999;353:282–286.
39.
Suresh M, Labia P, Mamtora H, Kalra PA: Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant 2000;15:631–636.
40.
Farmer CK, Cook GJ, Blake GM, Reidy J, Scoble JE: Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis. Nephrol Dial Transplant 2000;15:924–925.
41.
Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O’Donoghue DJ, Waldek S, Kalra PA: Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002;13:149–157.
42.
Wright JR, Duggal A, Thomas R, Reeve R, Roberts IS, Kalra PA: Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: Implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant 2001;16:765–770.
43.
Makanjulaa AD, Suresh M, Labio M, Kalra PA, Scoble JE: Proteinuria in Atherosclerotic renovascular disease. Q J Med 1999;92:515–518.
44.
Thadhani R, Pascual M, Nickeleit V, Tolkoff-Rubin N, Colvin R. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet 1996;347:231–233.
45.
Wright JR, Shurrab AE, Cheung C, Waldek S, O’Donoghue DJ, Foley RN, Mamtora H, Kalra PA: A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002;39:1153–1161.
46.
Isles C, Main J, O’Connell J, Brown I, Findlay J, Stewart R, Wilkinson R: Survival associated with renovascular disease in Glasgow and Newcastle: A collaborative study. Scot Med J 1990;33:70–73.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.